{"version":"1.0","provider_name":"ZLM","provider_url":"https:\/\/zlmsg.ch","author_name":"aid.admin","author_url":"https:\/\/zlmsg.ch\/author\/aid-admin\/","title":"Impact of rivaroxaban on point-of-care assays - ZLM","type":"rich","width":600,"height":338,"html":"
Impact of rivaroxaban on point-of-care assays<\/a><\/blockquote>